• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Meta-Analysis of Efficacy of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction.

作者信息

Salah Husam M, Fudim Marat, Al'Aref Subhi J, Khan Muhammad Shahzeb, Almarzooq Zaid I, Devabhaktuni Subodh R, Mentz Robert J, Butler Javed, Greene Stephen J

机构信息

Division of Cardiology, Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas.

Division of Cardiology, Duke University School of Medicine, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.

出版信息

Am J Cardiol. 2021 Apr 15;145:165-168. doi: 10.1016/j.amjcard.2021.01.013. Epub 2021 Jan 30.

DOI:10.1016/j.amjcard.2021.01.013
PMID:33529619
Abstract
摘要

相似文献

1
Meta-Analysis of Efficacy of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction.沙库巴曲缬沙坦对射血分数保留的心力衰竭疗效的Meta分析
Am J Cardiol. 2021 Apr 15;145:165-168. doi: 10.1016/j.amjcard.2021.01.013. Epub 2021 Jan 30.
2
Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction.沙库巴曲缬沙坦对射血分数保留的心力衰竭患者氨基末端 B 型利钠肽前体的影响。
JACC Heart Fail. 2020 May;8(5):372-381. doi: 10.1016/j.jchf.2020.03.002. Epub 2020 Mar 30.
3
Initial clinical experience with the first drug (sacubitril/valsartan) in a new class - angiotensin receptor neprilysin inhibitors in patients with heart failure with reduced left ventricular ejection fraction in Poland.在波兰，心力衰竭伴有射血分数降低的患者中，应用新型药物（沙库巴曲缬沙坦）——血管紧张素受体脑啡肽酶抑制剂的初步临床经验。
Kardiol Pol. 2018;76(2):381-387. doi: 10.5603/KP.a2017.0230. Epub 2017 Dec 1.
4
Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.射血分数对沙库巴曲缬沙坦（LCZ696）治疗射血分数降低的心力衰竭的疗效及预后的影响：ARNI与ACEI对心力衰竭全球死亡率和发病率影响的前瞻性比较（PARADIGM-HF）试验
Circ Heart Fail. 2016 Mar;9(3):e002744. doi: 10.1161/CIRCHEARTFAILURE.115.002744.
5
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure.沙库巴曲缬沙坦在心力衰竭射血分数谱中的应用。
Circulation. 2020 Feb 4;141(5):352-361. doi: 10.1161/CIRCULATIONAHA.119.044586. Epub 2019 Nov 17.
6
B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.沙库巴曲缬沙坦治疗期间的 B 型利钠肽：PARADIGM-HF 试验。
J Am Coll Cardiol. 2019 Mar 26;73(11):1264-1272. doi: 10.1016/j.jacc.2019.01.018. Epub 2019 Mar 4.
7
Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial.在射血分数保留的心力衰竭患者中，血管紧张素受体脑啡肽酶抑制剂 LCZ696 的降压作用和疗效的独立性：PARAMOUNT 试验分析。
Eur J Heart Fail. 2014 Jun;16(6):671-7. doi: 10.1002/ejhf.76. Epub 2014 Apr 1.
8
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.血管紧张素受体拮抗剂与中性内肽酶抑制剂联合使用
Circulation. 2016 Mar 15;133(11):1115-24. doi: 10.1161/CIRCULATIONAHA.115.018622.
9
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.血管紧张素-脑啡肽酶抑制剂在急性失代偿性心力衰竭中的应用。
N Engl J Med. 2019 Feb 7;380(6):539-548. doi: 10.1056/NEJMoa1812851. Epub 2018 Nov 11.
10
Sacubitril-valsartan: novel therapy for heart failure.沙库巴曲缬沙坦：心力衰竭的新型疗法。
Can Fam Physician. 2017 Sep;63(9):697.

引用本文的文献

1
Cardiometabolic heart failure with preserved ejection fraction: from molecular signatures to personalized treatment.射血分数保留的心脏代谢性心力衰竭：从分子特征到个性化治疗
Cardiovasc Diabetol. 2025 Jul 3;24(1):265. doi: 10.1186/s12933-025-02774-w.
2
Sex Differences in the Effectiveness of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Sacubitril-Valsartan for the Treatment of Heart Failure.血管紧张素转换酶抑制剂、血管紧张素 II 受体阻滞剂和沙库巴曲缬沙坦治疗心力衰竭的疗效的性别差异。
J Am Heart Assoc. 2023 Jul 18;12(14):e028865. doi: 10.1161/JAHA.122.028865. Epub 2023 Jul 8.
3
Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction.
非酒精性脂肪性肝病与射血分数保留的心力衰竭之间的关系
JACC Basic Transl Sci. 2021 Nov 22;6(11):918-932. doi: 10.1016/j.jacbts.2021.07.010. eCollection 2021 Nov.